Grants for Independent school districts - Federal

This funding opportunity provides financial support for research projects that develop and test nonopioid pain management strategies for Veterans and military personnel, focusing on integrating these approaches into standard healthcare practices.

This funding opportunity supports research projects that develop and test innovative interventions for individuals with substance use disorders involved in the criminal justice system, particularly focusing on improving treatment access and outcomes in diverse settings.

This grant provides funding for research on how climate change impacts cancer prevention, treatment, and survivorship, targeting a wide range of organizations including governments, universities, and nonprofits.

The "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes" grant aims to fund research projects that prepare for clinical trials in rare diseases by developing effective strategies for testing potential treatments or diagnostics, improving success rates with robust biomarkers and assessment measures, or by understanding the progression of a rare disease to better design future clinical trials.

This funding opportunity provides financial support to a variety of organizations to strengthen Ghana's public health system, focusing on improving disease prevention, detection, and response capabilities.

This funding opportunity supports research projects that advance the use of genomic information in clinical care, particularly for diverse and underserved populations, by providing financial assistance to a range of eligible organizations.

This grant provides funding for innovative research aimed at understanding the biological and immunological factors that contribute to the increased susceptibility of transgender individuals to HIV and other sexually transmitted infections.

The IIJA/IRA Bureau of Land Management National Operations Center (NOC) Recreation and Visitor Services Program grant aims to fund projects by state, local, and tribal governments, nonprofits, and educational institutions that enhance public land access, improve recreational opportunities, and strengthen visitor services, with a focus on climate resiliency, equitable access, and public stewardship, offering between $25,000 and $500,000 to successful applicants until September 30, 2024.

The purpose of this notice of funding opportunity (NOFO) is to invite applications for Research Centers (RC) to support the Centers for Research in Emerging Infectious Diseases (CREID) Network. The CREID network serves to expand knowledge on re-emerging and emerging infectious diseases (re/EIDs) around the globe where outbreaks are most likely to occur. Multi- and inter-disciplinary teams of domestic and international investigators will conduct innovative, collaborative One Health (approach that recognizes the health of humans is interconnected with that of animal health and the shared environment) based research projects and will mount a rapid and effective research response to outbreaks through coordination, collaboration, and cooperation across the CREID Network.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit grant applications from neutral, independent institutions and/or organizations to support meetings (e.g., conferences, workgroups, roundtables) that convene a broad range of multiple stakeholders, including those with relevant expertise, to explore, research, and address issues related to medical products, policy, and surveillance methods and systems. Support includes, but is not limited to the design, planning, execution, synthesis, summary, and communication of findings from these forums to a broad range of organizations and individuals.

This funding opportunity provides financial support for researchers and organizations to develop and validate innovative technologies that improve the understanding and treatment of cancer, with a focus on addressing unmet needs and health disparities.

This funding opportunity provides financial support to various organizations and governments to develop and implement trauma-informed services for children affected by violence in their homes, schools, and communities.

The National Cancer Institute intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for pilot/exploratory research on the confluence of cancer stigma and HIV stigma in HIV-positive individuals diagnosed with cancer. This NOFO will utilize the R21 grant mechanism (clinical trial optional), which is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Up to three (3) R21 awards are expected to be funded as part of the initiative. Research projects will advance the current understanding of the confluence of cancer stigma and HIV stigma in people with HIV (PWH) diagnosed with cancer; investigate the resultant impact of these dual stigmas on cancer outcomes among PWH with cancer; and promote research in diverse domestic and international contexts, focusing on regions in which the HIV-cancer burden is elevated. Pilot interventional research, which addresses modifiable mechanisms of stigma that contribute to negative cancer outcomes among PWH with cancer, is also suitable for this funding mechanism. The NOFO is expected to be published in late Summer 2024 with an expected application due date in late Fall 2024. Details of a pre-application webinar will be announced after the publication of the NOFO. This Notice is being provided to allow sufficient time for potential applicants with relevant expertise and insights to consider applying for this NOFO. Potential applicants are encouraged to view the presentation of this initiative to the Joint Virtual Meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board available at https://videocast.nih.gov/watch=54859 beginning at 3 hour, 39 minutes. Presentation slides are downloadable at: https://deainfo.nci.nih.gov/advisory/joint/0624/Vanderpool.pdf.

This funding opportunity provides financial support to schools and child nutrition programs to enhance access to locally sourced foods while integrating agricultural education activities.

This funding opportunity supports U.S. colleges and universities in developing programs that enhance diversity and provide research training for undergraduate students from underrepresented groups, preparing them for advanced biomedical research careers.

This funding opportunity provides financial support for research projects aimed at improving antibiotic use and reducing antibiotic resistance in healthcare settings, particularly in long-term care and outpatient environments.

USAID/DRCs vision for Kitumaini is a five-year long activity that will focus on service deliveryresults in five (5) health zones in Haut-Katanga, with possible expansion to other provinces asguided by Office of the Global AIDS Coordinator (OGAC)/PEPFAR. This activity also intends tostrengthen the capacity of local sub-recipients to enhance their capabilities to receive assistanceawards from USAID through transition award(s). This service delivery and capacity buildingactivity will include all aspects of HIV epidemic control. Activities will take place in health zonesassigned to USAID/DRC. This service delivery activity will prioritize services that focus on prioritypopulations, orphans and vulnerable children (OVC) and key populations (KP). The recipient willcoordinate with other implementing partners to facilitate the transition of the existing KPprogram, Meeting Targets and Maintaining Epidemic Control (EpiC) to Kitumaini.

HRSA-25-002, HRSA-25-003, and HRSA-25-004 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that there are 3 funding announcement numbers included in this document with 3 different periods of performance (See Appendix C). If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note: EIS is a subset of this 75 percent of the award) and; Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15. For more details, see Program Requirements and Expectations.

This funding opportunity supports innovative research on how environmental toxicants impact RNA modifications and their role in health issues, targeting universities, nonprofits, and for-profit organizations involved in related studies.

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) is a funding opportunity designed to support early-stage physicians and health professionals who are committed to aging and aging-related diseases research, helping them to enhance their research and leadership skills, establish independent research programs, and prepare to lead in their field to improve health outcomes for older individuals.